Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobanding  

作　　者：Asad Gul Rao Abdulqadir J Nashwan 

机构地区：[1]Department of Clinical Medicine,Dow Medical College,Karachi 74200,Pakistan [2]Department of Nursing&Midwifery Research,Hamad Medical Corporation,Doha 3050,Qatar

出　　处：《World Journal of Gastroenterology》2024年第36期4021-4024,共4页世界胃肠病学杂志（英文版）

摘　　要：Hemorrhoids are a common and painful condition,with conventional treatments such as endoscopic rubber band ligation(ERBL)and injection sclerotherapy often falling short due to high recurrence rates and significant post-operative pain.A clinical trial by Qu et al introduces a novel approach called endoscopic polidocanol foam sclerobanding(EFSB).This multicenter randomized trial involved 195 patients with grade II and III internal hemorrhoids and demonstrated that EFSB significantly reduced recurrence rates and post-procedural pain while improving symptom relief and patient satisfaction compared to ERBL.The study's strengths include its robust design,comprehensive outcome evaluation,and patient-centered approach.Despite limitations such as the single-blind design and relatively short follow-up period,the findings suggest that EFSB could enhance clinical practice by offering a more effective and patient-friendly treatment option.Further research is needed to validate these results and explore the long-term benefits and cost-effectiveness of EFSB.

关 键 词：HEMORRHOIDS Endoscopic polidocanol foam sclerobanding Rubber band ligation Injection sclerotherapy Hemorrhoids recurrence Post-operative pain 

分 类 号：R657.18[医药卫生—外科学]